The overall aims of MistraPharma phase 2 are to: (1) Identify high risk APIs
By generating new data with high relevance in environmental risk management
(2) Understand promotion of antibiotic resistance in the environment
By determining antibiotic resistance factors in contaminated environments and assessing different selection pressures
(3) Evaluate removal of high risk APIs through wastewater treatment
By assessing the feasibility of ozonation and/or activated carbon in wastewater treatment
(4) Contribute to the development of improved risk management
By improving the scientific basis for environmental classification, risk assessment and substitution
(5) Provide state-of-the-art analyses of APIs of environmental concern
By developing and quality assuring analytical methods
(6) Provide decision support to stakeholders
By communicating generated knowledge to ensure that it can be put to practical use
The following groups will participate in phase 2:
- Royal Institute of Technology, Div. of Philosophy, Prof. Christina Rudén
- Brunel University, Institute for the Environment, Prof. John Sumpter
- Uppsala University, Evolutionary Biology Center, Dept of Organismal Biology, Prof. Ingvar Brandt
- Stockholm University, Dep of Applied Environmental Science and Department of Systems Ecology, Assoc. Prof. Magnus Breitholtz
- Royal Institute of Technology, Div of Bioprocess Technology, Prof. Gen Larsson and Berndt Björlenius
- The Sahlgrenska Academy at the University of Gothenburg, Institute for Neuroscience and Physiology, Assoc. Prof. Joakim Larsson
- Chalmers University, of Technology, Department of Mathematical statistics, Assist. Prof. Erik Kristiansson
- Umeå University, Dep. of Chemistry, Prof. Mats Tysklind
- Stella Futura, Karin Liljelund
For more information please contact the programme director Christina Rudén at +46 (0)8 790 95 87 or email cr@infra.kth.se
